BFS container inspection should answer four different questions: is the filled amount within the agreed limits, is the ampoule formed and sealed correctly, can the customer open and dispense it as intended, and do the product records support batch release? A visual check alone cannot answer all four. Agree the specification, methods, acceptance criteria and responsibilities for the actual formula and production site before placing an order.
For a skincare brand comparing BFS manufacturers, the useful output is a product-specific inspection plan. The checklist below helps procurement, formulation and quality teams describe that plan. It does not claim that one test method or inspection percentage suits every cosmetic product.
Start with the product specification
Identify the formula revision, intended cosmetic use, polymer and mould reference, nominal fill, strip configuration, opening design and finished pack. An approved laboratory formula is not the same approval as a filled BFS ampoule. Record what the trial must establish and which changes require another review.
For example, a brand planning a five-ampoule serum carton should define the filled amount per ampoule, how each unit separates from the strip, opening instructions, the quantity a user can dispense and the carton count. This is a planning example, not a completed Steridose Labs customer project.
Six checks to agree with your BFS manufacturer
1. Filled amount and measurement
Ask how the filled quantity will be measured and how equipment checks, samples and acceptance limits will be recorded. If weight is used to assess a volume claim, agree the relevant formula density and measurement conditions. Headspace or the apparent liquid level is not a substitute for the agreed measurement method. Keep nominal fill and the quantity a customer can dispense as separate questions.
2. Container shape and visible defects
Agree the appearance reference for the ampoule, strip and filled product. Review deformation, incomplete forming, visible contamination, inconsistent appearance and other relevant defects using the proposed inspection conditions. A coloured or opaque formula can change what an operator or camera can see. Ask which defects the method can detect and how rejected units are identified and separated.
3. Seals and package integrity
Specify the seal or leak test separately from the visual check. Ask what the method detects, how it is verified for the actual container and formula, when checks take place and how failures are handled. Agree any additional assessment needed after handling, transport simulation or storage. A neat-looking seal does not by itself establish package integrity or the finished product shelf life.
4. Separation, opening and dispensing
Try the filled unit using the proposed instructions. Check strip separation, opening effort, edges, dispensing control and product remaining in the container. Record the formula and packaging versions used for the assessment. A cap that opens successfully on an empty pack does not establish the customer experience with a viscous serum.
5. Formula and finished-pack performance
Container inspection sits alongside formula compatibility, stability and applicable microbiological work. Discuss changes in colour, odour, texture, phase behaviour or the pack during the agreed assessment. Light-sensitive or oxygen-sensitive ingredients need product-specific protection evidence; a material name alone does not establish the finished package performance. Confirm the required work and approval dependencies before setting a launch date.
6. Identification, records and release
Connect the approved formula and packaging specifications to a batch identifier, inspection results, deviations and the release decision. Confirm labels, carton count, retained samples, storage conditions and the responsible party. Your team should know which records it will receive and which remain available for an agreed confidential review. Internal customer files do not need to be published on a website.
Turn the checklist into a short approval record
- Item: the formula, ampoule, strip or finished-pack feature being checked.
- Method: the agreed measurement or assessment, including its relevant conditions.
- Acceptance: the approved limit or reference and what counts as a failure.
- Coverage: when the check happens and the agreed sampling or unit-inspection approach.
- Owner: who performs the check, reviews a deviation and approves release.
- Record: the result, batch identification, decision and any required follow-up.
Define these fields before comparing quotations. A low filled-unit price and a quote including compatibility work, inspection, labels and assembled cartons describe different scopes. Separate one-time development or tooling from repeat-order manufacturing and testing costs.
Questions buyers often ask
Does automated BFS production mean every quality check is automatic?
No. Ask which checks are automated, which are sampled or manual, which defects each method can detect and what happens to rejected units. Specify the required coverage for your product rather than assuming it from a machine photograph or the BFS process name.
Can a clean-looking ampoule replace microbiological or stability testing?
No. Appearance, package integrity, microbiological quality and stability answer different questions. Agree the preservation approach, applicable testing and acceptance criteria for the formula and target market. Container inspection does not replace that work.
Does approving a formula sample approve commercial production?
No. Separate the formula sample, filled-unit trial and finished-pack approvals. State which tests and documents remain open at each stage and who accepts the results. A change to the formula, mould, material or process may require further assessment.
Plan your BFS skincare project
Steridose Labs coordinates formula development, adaptation or confidential transfer with BFS filling, labelling and finished packaging. Production starts at 10,000 filled BFS ampoules per formula; a lower quantity requires written factory confirmation. The assembled kit count is a separate quantity. The selected site, inspection methods, test scope and release responsibilities are confirmed for the project.
Start with our BFS skincare manufacturing service, review quality checks and document access, or send your formula status, target fill, quantity and market to discuss the checks needed for your order.
Technical references
Rommelag Engineering's Defect Library of Blow-Fill-Seal Containers is a technical reference for container defect discussions. Its classifications are a starting point for agreeing product-specific inspection criteria, not proof of a Steridose factory's equipment or results.
The FDA's cosmetics GMP inspection checklist provides general context on production controls, laboratory testing, batch identification and records. This reference supports the control categories discussed here; it does not certify Steridose Labs or establish an identical testing plan for every market.
Continue your product review
Use the matching guide to resolve the next formula, packaging or supplier decision.